ISSN 2515-8260
 

Technical Note 


A collaborative approach to encourage research and promote new treatments for orphan diseases

Lesley Greene.

Abstract
The last two decades has seen a significant increase in the development of medicinal products to treat rare “orphan” diseases, largely due to the EU Orphan Medicinal Product Regulation (2000), but also because of the consistent advocacy by patient groups prior to this regulation. These groups from across Europe joined forces under the umbrella of EURORDIS, to secure the implementation of the regulation and ensure that there was patient representation on the committee at EMA (the European Medicines Agency) which would be responsible for assessing and giving opinions on applications, namely COMP (The Committee for Orphan Medicinal Products). As its Vice-Chair I have the privilege to ensure the patient perspective is always considered during these assessments.

Key words: I will discuss how COMP works as part of the EMA Human Medicines Research and Development Support Division to promote the development of research into medicinal products for the treatment of rare diseases and how this is also encouraged by EU funding through Horizon 2020. Since rare diseases are a global issue, I describe how the EU is also collaborating with IRDiRC (the International Rare Disease Research Consortium) to provide the critical mass in t


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Lesley Greene
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Lesley Greene. A collaborative approach to encourage research and promote new treatments for orphan diseases. EJMCM. 2015; 2(2): 61-.


Web Style

Lesley Greene. A collaborative approach to encourage research and promote new treatments for orphan diseases. http://www.ejmcm.com/?mno=116562 [Access: June 19, 2020].


AMA (American Medical Association) Style

Lesley Greene. A collaborative approach to encourage research and promote new treatments for orphan diseases. EJMCM. 2015; 2(2): 61-.



Vancouver/ICMJE Style

Lesley Greene. A collaborative approach to encourage research and promote new treatments for orphan diseases. EJMCM. (2015), [cited June 19, 2020]; 2(2): 61-.



Harvard Style

Lesley Greene (2015) A collaborative approach to encourage research and promote new treatments for orphan diseases. EJMCM, 2 (2), 61-.



Turabian Style

Lesley Greene. 2015. A collaborative approach to encourage research and promote new treatments for orphan diseases. European Journal of Molecular & Clinical Medicine, 2 (2), 61-.



Chicago Style

Lesley Greene. "A collaborative approach to encourage research and promote new treatments for orphan diseases." European Journal of Molecular & Clinical Medicine 2 (2015), 61-.



MLA (The Modern Language Association) Style

Lesley Greene. "A collaborative approach to encourage research and promote new treatments for orphan diseases." European Journal of Molecular & Clinical Medicine 2.2 (2015), 61-. Print.



APA (American Psychological Association) Style

Lesley Greene (2015) A collaborative approach to encourage research and promote new treatments for orphan diseases. European Journal of Molecular & Clinical Medicine, 2 (2), 61-.